<DOC>
	<DOCNO>NCT02844933</DOCNO>
	<brief_summary>The primary objective study assess efficacy Cannabidiol Oral Solution hyperphagia-related behavior subject Prader-Willi Syndrome ( PWS ) , assess efficacy Cannabidiol Oral Solution body weight subject PWS .</brief_summary>
	<brief_title>Cannabidiol Oral Solution The Treatment Subjects With Prader-Willi Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Prader-Willi Syndrome</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Meets protocolspecified criterion qualification contraception Willing able remain confine study unit entire duration treatment period comply restriction relate food , drink medication Voluntarily consent participate provide write informed consent prior protocolspecific procedure History current use overthecounter medication , dietary supplement , drug ( include nicotine alcohol ) outside protocolspecified parameter Signs , symptoms history condition , per protocol opinion investigator , might compromise : 1. safety wellbeing participant study staff ; 2. safety wellbeing participant 's offspring ( pregnancy breastfeed ) ; 3. analysis result</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>